Device Trial Radar · NCT05848401
Biosound Therapy as a Treatment for Long COVID Patients
Last checked: Nov 19, 2026Latest source record: May 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Apr 29, 2021
Primary completion
Jan 5, 2022
Study completion Jan 19, 2022
Sponsor
- Lead sponsor
- Anxiety Relief CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 8, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 20 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aimed to explore the impact of the Biosound Therapy Systerm on long COVID symptoms while determining feasibility of a future full-scale Randomized Controlled Trial. It was hypothesized that Biosound treatment would significantly improve long COVID. The goal of this clinical trial is to learn about Biosound Therapy System's impact on long COVID symptoms. The main questions it aims to answer are: * How does Biosound Therapy impact long COVID symptoms? * Is the protocol for this trial feasible for a future full-scale Randomized Controlled Trial? Participants with long COVID symptoms will be assigned to a control group and treatment group. The control group will receive no treatment. The treatment group will have 8 sessions of Biosound Therapy. Researchers will compare the treatment and control group to see if there's a difference in long COVID symptoms.
Conditions
- Long COVID
Interventions
Biosound Therapy SystemDevice
Biosound Therapy consists of biofeedback, vibroacoustic therapy synchronized with music that plays binaural beats, and video content.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Patient Health Questionnaire (PHQ-9)Time frame: 4 weeks
- Generalized Anxiety Disorder 7-item scale (GAD-7)Time frame: 4 weeks
- Cambridge Brain Sciences (CBS) tasksTime frame: 4 weeks
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Anxiety Relief Center
Fishers, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.